These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 14652790)

  • 1. Imaging neuronal and axonal degeneration in multiple sclerosis.
    De Stefano N; Guidi L; Stromillo ML; Bartolozzi ML; Federico A
    Neurol Sci; 2003 Dec; 24 Suppl 5():S283-6. PubMed ID: 14652790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging axonal damage in multiple sclerosis by means of MR spectroscopy.
    De Stefano N; Narayanan S; Mortilla M; Guidi L; Bartolozzi ML; Federico A; Arnold DL
    Neurol Sci; 2000; 21(4 Suppl 2):S883-7. PubMed ID: 11205368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance spectroscopy as a measure of brain damage in multiple sclerosis.
    De Stefano N; Bartolozzi ML; Guidi L; Stromillo ML; Federico A
    J Neurol Sci; 2005 Jun; 233(1-2):203-8. PubMed ID: 15949506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences.
    Bjartmar C; Trapp BD
    Curr Opin Neurol; 2001 Jun; 14(3):271-8. PubMed ID: 11371748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability.
    De Stefano N; Narayanan S; Francis GS; Arnaoutelis R; Tartaglia MC; Antel JP; Matthews PM; Arnold DL
    Arch Neurol; 2001 Jan; 58(1):65-70. PubMed ID: 11176938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axonal injury and overall tissue loss are not related in primary progressive multiple sclerosis.
    Rovaris M; Gallo A; Falini A; Benedetti B; Rossi P; Comola M; Scotti G; Comi G; Filippi M
    Arch Neurol; 2005 Jun; 62(6):898-902. PubMed ID: 15956160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for adaptive functional changes in the cerebral cortex with axonal injury from multiple sclerosis.
    Reddy H; Narayanan S; Arnoutelis R; Jenkinson M; Antel J; Matthews PM; Arnold DL
    Brain; 2000 Nov; 123 ( Pt 11)():2314-20. PubMed ID: 11050031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal MR spectroscopy of neurodegeneration in multiple sclerosis with diffusion of the intra-axonal constituent
    Wood ET; Ercan E; Sati P; Cortese ICM; Ronen I; Reich DS
    Neuroimage Clin; 2017; 15():780-788. PubMed ID: 28702353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis.
    Abdel-Aziz K; Schneider T; Solanky BS; Yiannakas MC; Altmann DR; Wheeler-Kingshott CA; Peters AL; Day BL; Thompson AJ; Ciccarelli O
    Brain; 2015 Jun; 138(Pt 6):1568-82. PubMed ID: 25863355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Axonal degeneration in the pathogenesis of multiple sclerosis].
    Mirowska D; Członkowska A
    Neurol Neurochir Pol; 2002; 36(4):777-89. PubMed ID: 12418141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuronal injury in multiple sclerosis].
    Correale J; Meli F; Ysrraelit C
    Medicina (B Aires); 2006; 66(5):472-85. PubMed ID: 17137182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis.
    Filippi M; Bozzali M; Rovaris M; Gonen O; Kesavadas C; Ghezzi A; Martinelli V; Grossman RI; Scotti G; Comi G; Falini A
    Brain; 2003 Feb; 126(Pt 2):433-7. PubMed ID: 12538409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton MR spectroscopy to assess axonal damage in multiple sclerosis and other white matter disorders.
    De Stefano N; Narayanan S; Matthews PM; Mortilla M; Dotti MT; Federico A; Arnold DL
    J Neurovirol; 2000 May; 6 Suppl 2():S121-9. PubMed ID: 10871799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-Interferon treatment does not always slow the progression of axonal injury in multiple sclerosis.
    Parry A; Corkill R; Blamire AM; Palace J; Narayanan S; Arnold D; Styles P; Matthews PM
    J Neurol; 2003 Feb; 250(2):171-8. PubMed ID: 12574947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological indicators of the neurodegenerative phase of multiple sclerosis.
    Zaffaroni M
    Neurol Sci; 2003 Dec; 24 Suppl 5():S279-82. PubMed ID: 14652789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Axonal damage in multiple sclerosis].
    Bartosik-Psujek H; Stelmasiak Z
    Neurol Neurochir Pol; 2002; 36(3):505-12. PubMed ID: 12185807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulation of energy metabolism in multiple sclerosis measured in vivo with diffusion-weighted spectroscopy.
    Bodini B; Branzoli F; Poirion E; García-Lorenzo D; Didier M; Maillart E; Socha J; Bera G; Lubetzki C; Ronen I; Lehericy S; Stankoff B
    Mult Scler; 2018 Mar; 24(3):313-321. PubMed ID: 28394203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of brain and spinal cord atrophy in multiple sclerosis.
    Minagar A; Toledo EG; Alexander JS; Kelley RE
    J Neuroimaging; 2004 Jul; 14(3 Suppl):5S-10S. PubMed ID: 15228754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of retinal nerve fibre layer axons indicates white but not grey matter damage in early multiple sclerosis.
    Young KL; Brandt AU; Petzold A; Reitz LY; Lintze F; Paul F; Martin R; Schippling S
    Eur J Neurol; 2013 May; 20(5):803-11. PubMed ID: 23369013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in multiple sclerosis.
    Matthews PM; De Stefano N; Narayanan S; Francis GS; Wolinsky JS; Antel JP; Arnold DL
    Semin Neurol; 1998; 18(3):327-36. PubMed ID: 9817537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.